Agilent Technologies Inc (A)
139.22
+5.30
(+3.96%)
USD |
NYSE |
Apr 23, 15:33
Agilent Technologies Free Cash Flow: 1.649B for Jan. 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| January 31, 2024 | 1.649B |
| October 31, 2023 | 1.474B |
| July 31, 2023 | 1.42B |
| April 30, 2023 | 1.183B |
| January 31, 2023 | 1.061B |
| October 31, 2022 | 1.021B |
| July 31, 2022 | 1.022B |
| April 30, 2022 | 1.058B |
| January 31, 2022 | 1.28B |
| October 31, 2021 | 1.297B |
| July 31, 2021 | 1.268B |
| April 30, 2021 | 1.253B |
| January 31, 2021 | 1.092B |
| October 31, 2020 | 802.00M |
| July 31, 2020 | 736.00M |
| April 30, 2020 | 665.00M |
| January 31, 2020 | 598.00M |
| October 31, 2019 | 865.00M |
| July 31, 2019 | 917.00M |
| April 30, 2019 | 887.00M |
| January 31, 2019 | 929.00M |
| October 31, 2018 | 910.00M |
| July 31, 2018 | 804.00M |
| April 30, 2018 | 825.00M |
| January 31, 2018 | 784.00M |
| Date | Value |
|---|---|
| October 31, 2017 | 713.00M |
| July 31, 2017 | 665.00M |
| April 30, 2017 | 650.00M |
| January 31, 2017 | 665.00M |
| October 31, 2016 | 654.00M |
| July 31, 2016 | 686.00M |
| April 30, 2016 | 605.00M |
| January 31, 2016 | 539.00M |
| October 31, 2015 | 414.00M |
| July 31, 2015 | 341.00M |
| April 30, 2015 | 216.00M |
| January 31, 2015 | 325.00M |
| October 31, 2014 | 526.00M |
| July 31, 2014 | 730.00M |
| April 30, 2014 | 928.00M |
| January 31, 2014 | 920.00M |
| October 31, 2013 | 957.00M |
| July 31, 2013 | 1.035B |
| April 30, 2013 | 1.064B |
| January 31, 2013 | 1.116B |
| October 31, 2012 | 1.034B |
| July 31, 2012 | 1.071B |
| April 30, 2012 | 1.083B |
| January 31, 2012 | 1.094B |
| October 31, 2011 | 1.072B |
Free Cash Flow Range, Past 5 Years
598.00M
Minimum
Jan 2020
1.649B
Maximum
Jan 2024
1.077B
Average
1.060B
Median
Free Cash Flow Benchmarks
| Bio-Rad Laboratories Inc | 218.26M |
| Revvity Inc | 9.904M |
| Bruker Corp | 243.20M |
| Azenta Inc | 32.43M |
| Harvard Bioscience Inc | 11.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 485.00M |
| Cash from Investing (Quarterly) | -95.00M |
| Cash from Financing (Quarterly) | -240.00M |
| Free Cash Flow Per Share (Quarterly) | 1.344 |
| Free Cash Flow to Equity (Quarterly) | 575.00M |
| Free Cash Flow to Firm (Quarterly) | 398.45M |
| Free Cash Flow Yield | 4.01% |